NCT06331897

Brief Summary

Our goals is to assess : 1¬\_ the role of spirometer in case of asthma exacerbation 2\_hematological parameters (N/L ratio \& platelet indices \&CRP )in asthma exacerbation for diagnosing and classifying asthma severity and its exacerbation

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 26, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2026

Completed
Last Updated

March 26, 2024

Status Verified

March 1, 2024

Enrollment Period

1 year

First QC Date

March 16, 2024

Last Update Submit

March 24, 2024

Conditions

Bronchial Asthma

Outcome Measures

Primary Outcomes (1)

  • Assessment of Broncial asthma & its exacerbation : the utility of laboratory investigation , chest imaging , pulmonary function tests

    to assess : the role of spirometer in case of asthma exacerbation

    baseline

Eligibility Criteria

Age2 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

children group aged (2-18 years old ) who have bronchial asthma and its exacerbation

You may qualify if:

  • Clinical diagnosis of Bronchial asthma Disease
  • must be able to applied to spirometer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Central Study Contacts

Mohamed ragab kamel, resident pediatrician

CONTACT

+20 109 610 6605ibnragab34@gmail.com

emad hammad el daly, Professor of Pediatrics

CONTACT

emadhammad@aun.edu.eg

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident of Pediatrics department

Study Record Dates

First Submitted

March 16, 2024

First Posted

March 26, 2024

Study Start

January 1, 2025

Primary Completion

January 1, 2026

Study Completion

June 1, 2026

Last Updated

March 26, 2024

Record last verified: 2024-03